Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00887887
What this trial is testing

The Association Between Gene Polymorphisms and Infectious Complications After Liver Surgery

Who this might be right for
Liver Disease
Maastricht University Medical Center 100
Not applicableTemporarily Not AvailableNCT04081714
What this trial is testing

Intermediate Expanded Access Protocol CNMAu8.EAP03

Who this might be right for
Multiple Sclerosis
Clene Nanomedicine
Not applicableAvailableNCT04513821
What this trial is testing

Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI

Who this might be right for
Catheter-Related Infections
Leonard-Meron Biosciences, Inc.
Not applicableActive Not RecruitingNCT05647577
What this trial is testing

The Relationship Between Inflammatory ARTritis and CArdiac DIseAse

Who this might be right for
Inflammatory ArthritisRheumatoid ArthritisSpondylitis, Ankylosing+12 more
University Hospital, Gentofte, Copenhagen 1,285
Not applicableLooking for participantsNCT07056153
What this trial is testing

Association Between Early Consultation by the Primary Care Physician After Hospitalization in Geriatric Medicine Department, and the Risk of Re-hospitalization at 1 and 3 Months

Who this might be right for
Geriatric
Groupe Hospitalier Mutualiste de Grenoble 301
Testing effectiveness (Phase 2)Ended earlyNCT05953688
What this trial is testing

POC Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Active Intermediate, Posterior, or Pan NIU

Who this might be right for
Uveitis Posterior Non-InfectiousUveitis, IntermediateNoninfectious Panuveitis
Alumis Inc 36
Testing effectiveness (Phase 2)Study completedNCT01376362
What this trial is testing

Topical Interferon Gamma for Macular Edema Secondary to Uveitis

Who this might be right for
Anterior UveitisUveitis
National Eye Institute (NEI) 5
Not applicableStudy completedNCT07773441
What this trial is testing

Intermediate Wheatgrass Products and Gut Health

Who this might be right for
Gut HealthGastrointestinal SymptomsGut Microbiome+1 more
University of Minnesota 54
Very early researchUnknownNCT05612854
What this trial is testing

Catheter Directed Therapy in Intermediate Risk Pulmonary Embolism Patients

Who this might be right for
Pulmonary Embolism Subacute Massive
Assiut University 200
Not applicableStudy completedNCT03173586
What this trial is testing

Sugar Sweetened Beverage Intake and Biomarkers of Cardiometabolic Risk in US Women

Who this might be right for
Biomarkers
Harvard School of Public Health (HSPH) 33,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT02935361
What this trial is testing

Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed

Who this might be right for
Chronic Myelomonocytic LeukemiaMyelodysplastic SyndromeRecurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes
University of Southern California 33
Testing effectiveness (Phase 2)UnknownNCT03145961
What this trial is testing

A Trial Using ctDNA Blood Tests to Detect Cancer Cells After Standard Treatment to Trigger Additional Treatment in Early Stage Triple Negative Breast Cancer Patients

Who this might be right for
Triple Negative Breast Cancer
Institute of Cancer Research, United Kingdom 208
Testing effectiveness (Phase 2)Ended earlyNCT03946670
What this trial is testing

MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).

Who this might be right for
Myelodysplastic Syndromes
Novartis Pharmaceuticals 127
Not applicableUnknownNCT03622957
What this trial is testing

Association Between Phthalates Exposure and Renal Function Impairment in TYpe 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2AlbuminuriaCardiovascular Risk Factor
University of Pisa 200
Not applicableStudy completedNCT04403932
What this trial is testing

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Hospital San Carlos, Madrid 300
Post-approval studies (Phase 4)Study completedNCT04513522
What this trial is testing

Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India

Who this might be right for
Kidney Neoplasms
Bristol-Myers Squibb 101
Not applicableNot Yet RecruitingNCT07210502
What this trial is testing

Side Effects of Low Dose Rate Brachytherapy and Ultra-hypofractionated Radiotherapy in Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Royal Surrey County Hospital NHS Foundation Trust 220
Not applicableActive Not RecruitingNCT02339701
What this trial is testing

Stereotactic Body Radiotherapy vs Intensity-modulated Radiotherapy in Prostate Cancer

Who this might be right for
Prostate Cancer
Chinese University of Hong Kong 68
Not applicableLooking for participantsNCT07015112
What this trial is testing

Applying a Multidisciplinary Intervention for Drug Adequacy in an Intermediate Care Hospital (AMIDA-ICH)

Who this might be right for
Poly PharmacyFrail Elderly
Parc Sanitari Pere Virgili 300
Not applicableLooking for participantsNCT06354881
What this trial is testing

The Relationship Between Controlling Risk Factors and Cerebral Haemodynamics in Lacunar Stroke

Who this might be right for
Lacunar Stroke
University of Leicester 75
Next Page